as manifested by tachycardia, tachypnea, hepatomegaly, cardiomegaly and increased pulmonary blood flow on chest x-ray. M-mode echocardiograms documented a mean ratio of left atrial to aortic size of 1.5 ± 0. 1, and a left ventricular shortening fraction of 0.35 ± 0.03. Therapy for congestive heart failure, which consisted of digoxin, chlorothiazide and spironolactone, was administered to each patient before catheterization, although not within 12 hours before the study.
Informed consent for participation in this study was obtained. Four infants received chloralhydrate (25 mg/kg) and one received morphine sulphate (0.15 mg/kg) and benadryl (1 mg/kg) for sedation. Routine right-and left-heart catheterization was performed. Once the presence of an isolated large VSD was confirmed, and before angiography, nitroprusside infusion was begun through the proximal port of a #5F double-lumen catheter. The initial dose of 0.5 ,ug/kg/min was increased by increments of 0.5 ,ug/kg every 5 minutes until either aortic systolic pressure dropped by 15% or the maximal dose of 2.0 ,ug/kg/min was reached. Before the nitroprusside infusion, after 5 minutes at each nitroprusside dose, and 10 minutes after the infusion was discontinued the following data were collected: aortic, pulmonary capillary wedge, pulmonary artery, and right atrial pressures; aortic, pulmonary artery, and superior vena cava oxygen saturations; heart rate; and oxygen consumption (using a continuous-flow system20). Control data were measured during the 20 minutes before nitroprusside infusion. Blood flows, shunts and resistances were calculated in accordance with the Fick principle. Finally, left ventricular cineangiography confirmed the presence of a large VSD in each patient. One patient also had a small patent ductus arteriosus.
The data were evaluated by the two-tailed t test for The dose-related effects of nitroprusside on several hemodynamic variables are shown in figure 1 . Most values changed gradually and returned toward prenitroprusside baseline levels when the infusion was stopped. Significant hemodynamic effects were first observed at an infusion rate of 1 ug/kg/min, which was the maximal dose received by two infants. A further gradual increase to 2 ug/kg/min produced significant hemodynamic changes in the other three infants. Systemic blood flow and pulmonary-to-systemic flow ratio did not improve significantly at any dose. Instead, these variables deteriorated in each infant, although at different nitroprusside doses.
The maximal dose of nitroprusside varied (two patients 1.0 ,ug/kg/min, three patients 2.0 gg/kg/ min), so control data were compared with data obtained at the maximal dose for each patient (table 2) . Baseline values before and after nitroprusside infusion were not significantly different, with the exception of pulmonary capillary wedge pressure, which remained slightly decreased after nitroprusside (p < 0.05).
Nitroprusside had a significant effect on arterial and venous pressures ( fig. 2 ). Aortic mean pressure decreased from 63.6 to 54.6 mm Hg (p < 0.05), while pulmonary artery mean pressure decreased from 41.4 to 32.0 mm Hg (p < 0.05). Left and right ventricular filling pressures also decreased with nitroprusside. between April 1979 and May 1980 (table 3) . Premedication, catheterization techniques, and oxygen consumption measurements were as described above. No statistical difference in any clinical or hemodynamic variable was found between the study group and the group of all infants who had a large VSD and congestive failure and were catheterized. It appears, therefore, that the study group adequately represents the larger group of infants with an isolated large VSD.
Discussion
This study shows an adverse hemodynamic response to nitroprusside in infants with a large VSD and congestive heart failure in that systemic flow decreases and the pulmonary-to-systemic flow ratio increases significantly. Although right atrial and pulmonary capillary wedge pressures decrease significantly in response to nitroprusside's venodilator effect,21 pul- Nitroprusside usually causes a decrease in systemic arterial resistance; however, in these infants an unexpected increase in systemic resistance was observed. Reflex sympathetic vasoconstriction and the marked decrease in systemic flow that occurred with nitroprusside probably explain this apparently paradoxical increase in systemic resistance. The increase in heart rate is additional evidence of increased sympathetic activity, which is probably baroreceptor-mediated in response to the decrease in aortic pressure. 2 These findings contrast with previous reports on the effects of vasodilator agents in animal and human subjects. Synhorst et 
al.18 documented a decrease in left-
to-right shunting in response to phentolamine or phenoxybenzamine in dogs with an experimental VSD. These a-blocking drugs have little effect on venous capacitance vessels; in fact, before the experiment, each dog was volume loaded with an equivalent of 20% of its total blood volume. Because the infants in the present study were in congestive failure, no attempt was made to keep ventricular preload constant by means of volume infusion. A decline in ventricular performance during nitroprusside infusion has been well documented in adults with heart failure and is related to relatively low filling pressures. Optimal performance is attained only when ventricular preload is maintained at or just above normal levels.1 22 The present data suggest that as ventricular preload, and perhaps performance, decrease in response to nitroprusside, the presence of a large interventricular communication permits a greater portion of the total cardiac output to enter the lower resistance pulmonary circulation. The net effect is to increase the left-to-right-shunt at the expense of systemic blood flow.
Previous work in human subjects has clearly documented hemodynamic improvement with nitroprusside in patients with congestive heart failure.8-'7 These studies, however, evaluated patients who were characterized by depressed ventricular function, low systemic flow, and elevated systemic resistance. The data in table 3 are consistent with previous reports23-25 that suggest that this classic profile of the patient with congestive heart failure may not apply to infants with a large, isolated VSD. These infants, with overt signs and symptoms of heart failure, have normal cardiac indexes and systemic resistance and only mildly elevated left ventricular end-diastolic pressure. In addition, left ventricular shortening fraction is normal or increased, as assessed by echocardiography. Thus, ventricular performance appears to be normal in infants with a large interventricular shunt and congestive failure and, despite clinical similarities, their hemodynamics differ considerably from those of patients with depressed ventricular function. That nitroprusside exerts very different effects in these two groups of patients is, therefore, not surprising. Depressed ventricular performance, low cardiac output and high systemic resistance may be prerequisites of a favorable response to nitroprusside.
In conclusion, nitroprusside exerts adverse hemodynamic effects in infants with a large VSD and congestive failure. It causes a marked decrease in systemic blood flow and an increase in the pulmonary-tosystemic flow ratio. These findings may be related to the hemodynamic profile of these infants, in whom ventricular performance, cardiac output and systemic resistance are normal. Under such circumstances the venodilator action of nitroprusside appears to predominate. Careful maintenance of ventricular preload by means of volume infusion may improve the response of such infants to administration of nitroprusside. had undergone cardiac catheterization and axial angiocardiographic studies a few weeks before death. Each had tetralogy of Fallot with concordant atrioventricular connections, a large VSD in the left ventricular outflow septal area, biventricular origin of the aorta, origin of the pulmonary artery from the right ventricle, infundibular pulmonary stenosis and right ventricular hypertrophy." The specimens were selected on the basis of availability of angiographic and anatomic correlation. They had been fixed in formalin and opened in the usual fashion. The right ventricular incision was always extended into the pulmonary artery and the aorta opened from the left ventricle. This allowed clear definition of the VSD and its relation with the arterial and atrioventricular valves from either ventricle. The surgically placed patches were removed in all cases. The amount of infundibular and anterior right muscle wall removed by the surgeons varied from case to case according to the need at operation.
The catheterization had been performed under general anesthesia and angiograms made after obtaining hemodynamic and saturation data. Biplane 35-mm cineangiograms were made with injection of Renografin-76 through a large NIH catheter with side holes. Hand injection was used routinely, although power injection was used in larger patients or when smaller catheters were necessary.
Angiograms were made simultaneously in the longaxis and elongated right anterior oblique views after injection into the right ventricle. Left ventriculo-
